根据向美国证券交易委员会（SEC）提交的文件，医疗技术公司Nuwellis, Inc.宣布其董事会批准的1股合10股的反向股票拆分计划，将于2026年6月25日正式生效。
在反向拆股生效当日，即2026年6月25日，公司普通股将以拆股调整后的新代码在纳斯达克资本市场开始交易。此次反向拆股旨在提升公司每股股价，以满足纳斯达克持续上市的最低股价要求。
公司股东无需就此次反向拆股采取任何行动。拆分比例调整后，每位股东所持公司总权益的比例将保持不变。拆股完成后，公司的授权股本数量将按比例减少。
反向拆股是上市公司为应对股价持续低于交易所要求而采取的一种常见资本结构调整手段。此举通常旨在重塑市场形象，并吸引更广泛的机构投资者关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.